QuickView for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=4528C92532BBC80F364C5724FB5F46CA;jsessionid=9B4D5A7C7AB117ED9E3E04C1F89E04C2;jsessionid=8652FCAC1070B925DC9F4591FE848C52;jsessionid=184B3DB47D51E40D1607AF7CB49DA771;jsessionid=95839EA852A3062D104BD5C10430D899 (gene)

1. ATXN2 intermediate expansions in amyotrophic lateral sclerosis.
2. Missense mutation in ATXN2 gene (c.2860C > T) in an amyotrophic lateral sclerosis patient with aggre…
3. The RNA-binding protein and stress granule component ATAXIN-2 is expressed in mouse and human tissue…
4. Ataxin-2 gene: a powerful modulator of neurological disorders.
5. Antagonistic roles for Ataxin-2 structured and disordered domains in RNP condensation.

There were no clinical trials for TNRC13;jsessionid=3D765BD25ABDC6EF1EDE0A75B9F1BD6C;jsessionid=A8AB09FA390A3AE4E0D1D6F38BF237B8;jsessionid=51586F57457820B19218871CCD1B1B0A;jsessionid=1378266A38B81A4711AC8DCC93F77B7F;jsessionid=4528C92532BBC80F364C5724FB5F46CA;jsessionid=9B4D5A7C7AB117ED9E3E04C1F89E04C2;jsessionid=8652FCAC1070B925DC9F4591FE848C52;jsessionid=184B3DB47D51E40D1607AF7CB49DA771;jsessionid=95839EA852A3062D104BD5C10430D899